View in EDS

Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis.

Saved in:

Bibliographic Details
Title:	Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis.
Authors:	Kian W; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University., Zemel M; Medical School for International Health, Ben-Gurion University of the Negev., Elobra F; Dermatology Department Soroka Medical Center & Ben-Gurion University., Sharb AA; Internal Medicine Ward, Soroka Medical Center & Ben-Gurion University., Levitas D; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University., Assabag Y; Internal Medicine Ward, Soroka Medical Center & Ben-Gurion University., Alguayn F; Faculty of Health Sciences, Ben-Gurion University of the Negev., Yakobson A; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University., Rouvinov K; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University., Fuchs L; Medical Intensive care Unit, Soroka University Medical Center, Beer-Sheva, Israel.
Source:	Anti-cancer drugs [Anticancer Drugs] 2022 Jan 01; Vol. 33 (1), pp. e738-e740.
Publication Type:	Case Reports; Journal Article
Journal Info:	Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1473-5741
DOI:	10.1097/CAD.0000000000001162